Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10967429 | Vaccine | 2012 | 8 Pages |
Abstract
This experience provides lessons about epidemiological unpredictability, preparedness, vaccine manufacturing, the potential global importance of vaccine seed materials and the advisability of a global strategic plan. Consideration should be given to banking of vaccine production seeds, cell substrates, and manufacturing instructions. In view of the manufacturability, attenuation, and immunogenicity of Chikungunya Vaccine TSI-GSD-218, authorities may wish to consider this product as a possible candidate itself, as a comparator vaccine to improve upon, as a seed for inactivated vaccine, or as a source of virus or antigen for neutralization assays or immunoassays.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Charles H. Jr., Judy Pace-Templeton, Phillip Pittman, Frank J. Malinoski, Paul Gibbs, Tracy Ulderich, Michelle Mathers, Beverly Fogtman, Pamela Glass, David W. Vaughn,